Smoking continues to be the number one cause of
preventable death in the United States and is a
significant public health problem.1 Effective
methods are available to assist smokers with cessation,
including pharmacotherapy (nicotine replacement therapy
or bupropion hydrochloride) and group or individual
behavioral counseling. Investigations of the effect of
brief physician advice have yielded quit rates of approximately
10% at 1 year.2 Pharmacotherapy, in addition to
brief physician advice, can boost these results to 15% to
25%.3-5 However, the addition of behavioral counseling
along with pharmacotherapy demonstrates the highest
quit rates of 25% to 36% at 1 year.6,7
Although many smokers attempting cessation use
some type of adjunctive pharmacotherapy, many do not
access telephone quitline services that are available to
them. Previous research identifies that only 2.4% of
smokers with partial health insurance coverage and 10%
of smokers with full coverage will use smoking cessation
services, including a behavioral program and nicotine
replacement therapy, within 1 year.8 Methods for
encouraging participation in quitline programs are
needed. Recruitment methods can make a difference in
the overall participation in a program. Most recruitment
strategies are passive, in which subjects are informed
about the availability of a program through advertising,
such as newsletters, television, and newspapers, and the
participant makes the initial contact to the program for
enrollment. In contrast, proactive recruitment occurs
when the program identifies eligible subjects and contacts
the subjects directly (through mail, electronic
communication, or, most commonly, telephone calls) to
offer services.9 Passive approaches typically result in
lower participation levels,10 and passively recruited
study samples tend to be different from proactively
recruited samples. Passively recruited participants are
more likely to be ready to change, more highly educated,
and predominantly female.11
Research regarding proactive strategies reveals that
they are an effective method of recruiting targeted
groups to services.12,13 Prochaska et al9 found that 80%
of smokers who were proactively "cold-called" by telephone
participated in a smoking cessation intervention,
and Lando et al14 found that smokers were receptive to
proactive telephone calls offering assistance with quitting.
Britt and colleagues15 found high acceptance of
proactive telephone calls for smoking cessation, even
among smokers not yet contemplating quitting, with
86% of all contacted smokers accepting at least 1 telephone
counseling call. "Telephone outreach procedures
may be a useful channel for increasing the proportion of
smokers recruited into treatment," conclude Lando and
colleagues.14,p45
Because proactive strategies are typically much more
effective in recruiting participants than passive strategies,
they also tend to be more cost effective. Previous
studies16,17 of the proactive activities of quitlines have
found the additional costs to be inexpensive. Yet, for
proactive identification of smokers to occur, there must
be a mechanism in place to identify a target group.
Identification of smokers using nicotine replacement
therapy or bupropion through pharmacy claims may be
a strategy to identify smokers ready to quit in a health
plan population, and quitline participation can increase
their success with cessation.
A major health plan based in the midwestern United
States was interested in increasing the use of quitline
services among members who smoke. The objective of
this study was to determine if proactive recruitment of
health plan members filing a claim for smoking cessation
pharmacotherapy was effective in increasing participation
in quitline services. The costs associated with
such recruitment are also calculated. This study may
serve as a model for other health plans in applying
proactive outreach measures.
METHODS
Subjects
Study subjects were health plan members of a large
open-access health insurance company serving nearly
5 million covered lives. These subjects had filled a prescription
for smoking cessation pharmacotherapy.
Subjects were enrolled in a preferred provider organization
or a traditional fee-for-service insurance plan
and had pharmacy benefit coverage through these
plans (a subset of the total insured population).
Pharmacy benefits for smoking cessation included
bupropion and nicotine replacement products, such as
the nicotine patch, gum, inhaler, and spray. Members
who did not have health plan coverage for pharmacotherapy
or otherwise made out-of-pocket purchases
for over-the-counter nicotine replacement products
were not considered as subjects for this study. Persons
were considered ineligible for participation in the study
if they (1) were a member of the health plan's health
maintenance organization (excluded because of recent
receipt of postcard mailings encouraging quitline participation),
(2) lacked an address or telephone number
on file, (3) were previously enrolled in the quitline program,
or (4) were a patient of a provider enrolled in a
larger ongoing study of smoking cessation interventions.
Because members included in the study had
already filled a prescription for smoking cessation
pharmacotherapy, this group appeared to have inherent
motivation to quit smoking.
Study Design and Procedures
The study was approved by the University
Committee for Research Involving Human Subjects at
Michigan State University. The study design was a randomized
controlled trial. A priori sample size calculations
assuming a 3% baseline enrollment rate indicated
that 134 subjects were needed in each group to detect a
10% absolute difference between the control and each
intervention group with 80% power and a significance
level of P < .05. Identification of subjects was done by a
weekly query to the insurance plan's pharmacy claims
database. Members with a claim for smoking cessation
pharmacotherapy were listed. This list was then crosschecked
with the relevant databases, and members
were eliminated if they were found to have 1 or more of
the ineligibility criteria. The remaining members were
considered eligible for study participation and were randomized
to 1 of the following 3 conditions: control
(usual procedure, ie, passive recruitment in which
smokers learn about the quitline from providers or
newsletters and self-contact the quitline), recruitment
postcard, or recruitment telephone call by a nurse quitline
counselor. The randomization to conditions was a
2:1:1 ratio, with the recruitment telephone call condition
having twice the assigned sample size to accommodate
the expected modest contact rate. Subject
identification began in March 2003 and continued until
at least 134 subjects were identified for each group,
which occurred in July 2003.
Intervention
The control group received no direct contact other
than the typical communications, such as the quitline
telephone number listed in the health plan newsletter.
There were 2 intervention groups, the postcard group
and the telephone call group. The postcard group was
sent 1 of 2 postcards normally used by the health plan
to encourage participation in the quitline containing 1
of the following 2 motivational messages: "Want an
extra $2000 next year?" or "Quit smoking! No charge.
No hassle. No joke." Each included the quitline telephone number to call and messages about the programs
being free of charge and offering 24/7 telephone-based
enrollment, nurse counselor support, and educational
tools.
The telephone call group received a personal call
from a smoking cessation quitline nurse. No letters were
sent, so the telephone call was effectively a "cold call"
from the quitline nurse. The content of the call included
a brief motivational message, description of the quitline
program, and an invitation for the member to
enroll. The quitline program is based on a model of
counselor support and relapse prevention. Participants
are offered 1 of 2 levels of participation and were offered
the option of selecting participation in level 1, in level 2,
or not at all. Level 1 requires the participant to set a quit
date within the next 14 days and includes an intake session
and 6 sessions at intervals of 1, 3, 7, 14, 30, and 60
days after the quit date, with follow-up at 90, 180, and
360 days after the quit date. This follows the typical
relapse curve after attempts at smoking cessation.6
Level 2 is for participants not ready to set a quit date
within the next 14 days, and participants are instead
sent educational materials and receive a series of telephone
callbacks (at which time participants enter level
1 or drop out). For both levels, all follow-ups and contacts
are conducted by telephone.
Data Collection
Subjects in the telephone call group were asked additional
questions by the nurse. This included the member's
reason for not signing up for the program (if he or
she did not enroll); whether the member had already
quit smoking (7-day quit) and, if yes, his or her success
with this attempt to quit; the type of smoking cessation
product used; and the member's rating of his or her
value placed on and confidence in quitting smoking
(score range, 1, not important or not confident, to 10,
very important or very confident). Nurses made up to 4
contact attempts, calling at different times of day and
leaving messages before considering the member a noncontacted
subject. Consent to use the data was obtained
verbally by the nurse during telephone call contacts.
Enrollment into the quitline program was tracked for 35
days after the data pull.
Data Analysis
Enrollment rate differences between the control and
intervention groups were compared using the Fisher
exact test. Any further differences between the groups
were compared using the Fisher exact test for categorical
variables and the 2-tailed unpaired t test or the 2-sample Wilcoxon signed rank test for continuous
variables, as appropriate. All analyses were conducted
using SAS statistical software, version 8.02 (SAS
Institute Inc, Cary, NC).
To calculate costs, the resource costs were used for
the proactive interventions. The mean annual salary and
benefit costs were applied to 39.5 hours of the nurse's
time ($54 600) and to 33.5 hours of administrative staff
time ($72 602 for an analyst and $26 000 for a clerk),
while actual costs were used for supplies ($0.31 per
mailed postcard and $1.25 per mailed educational materials
package, which included a coping tips booklet, personal
diary, and "Clearing the Air" brochure). Costs
were categorized as fixed or variable, an important difference
in that the latter costs are incurred and change
with the intervention levels. Because the quitline program
was already purchased, available, and staffed, its
cost represented a fixed cost. Increased use of the program
associated with the interventions did not result in
an incremental, marginal cost increase relative to the
control group, although in the long run, more volume
would be expected to generate higher mean costs.
RESULTS
Subjects
For all members in the study, the mean ± SD age was
49.1 ± 12.6 years, and the sex distribution was 50.4%
female and 49.6% male. There was no significant difference
by group in age or sex. Additional demographic
data were not available. Most claims were for bupropion
(366 claims [58.6%]), followed by nicotine inhaler (138
claims [22.1%]), nicotine patch (101 claims [16.2%]),
and nicotine nasal spray (20 claims [3.2%]).
For those in the telephone call group, among 146 contacted,
the sex distribution was 50.6% female, with a mean
age of 48.8 years. Bupropion was again the most common
pharmacotherapy (77 claims [52.7%]), followed by nicotine
inhaler (38 claims [26.0%]), nicotine patch (24 claims
[16.4%]), nicotine nasal spray (7 claims [4.8%]), and a
combination of 2 products (7 claims [4.8%]).
Recruitment
The Figure outlines the flow of participants through
the study, including exclusions, randomization to
groups, contact rates, and enrollment into the quitline
program. Regarding the contact rate, 155 of 156 postcards
that were mailed successfully reached their recipients.
The contact rate among the telephone call group
was 46.8% (146/312). Of the 166 persons unable to be
contacted by telephone, 75.3% (125/166) were due to
nonresponse, despite multiple contact attempts.
Enrollment
Increased enrollment into the quitline program was
significant by randomization group (P < .001). This
significance remained when the telephone call group
sample size was considered to be 312 (intention to
treat) or 146 (contacted). Of those contacted, the
enrollment rate was 43.8% (64/146) for any level of
the program and 15.1% (22/146) for level 1 only. Of
those enrolling, most (n = 42) enrolled in level 2 of
the program, which provides educational information
and periodic telephone callbacks. Level 1 initiates the
counseling program, setting a quit date within the
next 14 days and a series of telephone counseling
calls. The mean ± SD time to contact from the prescription
fill date to the nurse telephone call was 15.6
± 1.6 days.
Other data were gathered for those contacted in the
telephone call group. Of 146 contacted, 7 declined
answering the additional questions, leaving 139 in the
expanded data set. As noted in Table 1, about half of
the group self-reported that they had already quit
smoking and were self-identified as "smoke free" by
the time of the telephone call. The value placed on
quitting was rated as high (mean ± SD score, 9.4 ±
1.6), as was the confidence in quitting (mean ± SD
score, 8.1 ± 2.6). The enrolled group was significantly
older (51.9 vs 48.1 years; P = .03, paired t test) than
those not enrolling, although there was no significant
difference in the sex distribution. Two other factors
were significantly predictive of quitline enrollment:
(1) having quit and relapsed vs remaining smoke free
at contact (52.9% vs 19.2% enrollment; P < .001, Fisher
exact test) and (2) reporting a lower vs higher confidence
in quitting (mean score, 7.7 vs 8.5; P = .04, 2-sample Wilcoxon signed rank test). Those who had
already quit reported higher scores for the value
placed on quitting (mean score, 9.8 vs 8.9; P = .001)
and their confidence in quitting (mean score, 9.0 vs
7.2; P < .001). We only measured quit rates in the telephone
call group; at 60 days after enrollment, 4 subjects
remained in the quitline program and had quit
smoking. The quit rate in this group (18.2% [4/22
entering level 1]) was similar to the usual member-reported
quit rates for the program.
The literature indicates that smokers using pharmacotherapy
and quitline counseling have quit rates
of 25% or higher.6,7 Among those receiving brief physician
advice and pharmacotherapy, the quit rates are
15% to 25%.3-5 Extrapolating to the subjects in this
study, we estimate that 25% of the 22 level-1 enrollees
and 15% of the 42 level-2 enrollees quit smoking,
resulting in 12 smokers who quit in the telephone call
group. We estimate that there would have been 0.5
smokers who quit in the postcard group (25% of 2
enrollees).
Cost Analysis
The costs associated with the postcard and telephone
call interventions per outcome are shown in Table 2.
The total costs were $3389 for the postcard intervention
and $4766 for the telephone call intervention.
The summary of incremental costs (ie, the variable
costs, a portion of the total costs) were $146.50 for the
postcard intervention and $1523.20 for the telephone
call intervention, or $73.25 and $23.80 per
total program contact, respectively. Although the total
investment of personally contacting individuals by
telephone call is high relative to the postcard group,
the resulting enrollment makes it the less costly way of
encouraging participation when evaluated on a cost-per-enrollee basis. To calculate the costs per smoker
who quit, 2 methods were used. First, actual quit rates
among level-1 enrollees at 60 days after enrollment
revealed total costs per smoker who quit of $1191 and
incremental costs per smoker who quit (with the addition
of the proactive telephone calls) of $380.73. All
smokers who quit were in the telephone call group.
Second, using estimated quit rates based on the literature,3-7 extrapolated to this study, we would expect
higher numbers of quitters, as already noted, of 0.5 in
the postcard group and 12 in the telephone call group,
reducing the total and incremental costs per smoker
who quit in the telephone call group.
DISCUSSION
The key findings of this study were that proactive
telephone calling of members filing claims for smoking
cessation pharmacotherapy can be an effective method
of recruiting these smokers into quitline participation.
Smokers who have quit and relapsed are more likely to
enroll than those who have quit and maintained cessation.
Because 95% to 98% of untreated smokers and 70%
to 80% of treated smokers will relapse, this finding may
prove valuable in understanding how to sustain quit
rates.18,19 The postcard mailing was ineffective in influencing
participation in the program.
These results were similar to those found by others.
Zhu et al20 found that proactive telephone counseling
was a promising adjuvant treatment for nicotine
replacement therapy users. Nicotine replacement therapy
users who received follow-up telephone sessions
were more likely to succeed in smoking cessation in the
long term than those receiving only a single counseling
session (25.6% vs 16.1% at 1 year). There was a dose-response
relationship between counseling intensity and
treatment effect. McDonald13 found that telephone and
other interpersonal recruitment strategies produce
results superior to those of media or mail, whether used
independently or in combination with one another.
Two thirds of the enrollees were to level 2 of the quitline
program, providing educational materials and periodic
callbacks, rather than to level 1 of the program,
which requires setting a quit date within 14 days.
Possible reasons for the greater level-2 enrollment
include participants' being interested in some level of
assistance but not the complete program, not being
ready to quit within 14 days (ie, they preferred to set a
quit date at a later time), or simply not wanting to say
no to the nurse counselor.
The length of time it takes to contact the participant
is an issue for other health plans to consider in implementing
similar interventions. A lag in contact was
largely a result of how current the data were in the pharmacy
database. In most health plans, getting pharmacy
data less than a week old is problematic. This may have
been a factor in the low enrollment; however, many participants
were simply averse to the idea of participating
in a program (30.1% did not believe that they needed a
program or did not like the idea of a program). Yet, in
most cases, members agreed to accept the telephone
call and answer questions. Another consideration is the
limited reliability of telephone numbers in health plan
databases, which adds to the burden of staff who are
contacting participants. In this study, half of the participants
were not reachable by telephone in up to 4 contact
attempts, and this was among members who had a
telephone number on file.
Although the total costs per participant were higher
in the telephone call group, the enrollment rate was also
higher than in the postcard group or the control group,
which brought the cost per enrolled participant down
and made the telephone call group the most cost effective
of the intervention and control groups. Resource
costs of the interventions were
minimal, compared with the
cost of running the quitline
program. In this case,
increased use of the quitline
can be considered an additional
benefit of the study to the
extent that it helps fill unused
program capacity. If the intervention
had led to increased
use of the quitline beyond the
existing program capacity, then
the additional resource costs
would need to be considered in
this analysis. Staff costs may be
further reduced by the use of
trained nonclinical personnel,
a strategy that has been shown
to be effective in quitlines.21
Limitations of this study
include the selection bias of the
study sample, which did not
include the health maintenance
organization members of the health plan, subjects not
having smoking cessation pharmacotherapy coverage,
subjects not needing or seeking pharmacotherapy, and
subjects having providers enrolled in a larger ongoing
study. The size of the subject pool was small, and self-report
data from the telephone call group did not include
a specific time frame regarding cessation experience.
Quit rates were not validated by carbon monoxide or
cotinine tests, although research on cessation data by
self-report is reliable.22,23 Beyond age and sex, additional
demographic data were not available, and quit rates and
further information on subjects in the control group and
the postcard group were not available.
In summary, proactive telephone recruitment of health
plan members receiving pharmacotherapy for smoking
cessation was effective in enrolling members to participate
in quitline counseling. Health plans should consider
proactive telephone recruitment to improve the use
of quitline services with excess program capacity.
Acknowledgments
We thank Rene Jarinski, RN, Carol Lingl, RN, and Ruth De Vine, RN, for
assistance with the proactive telephone calls.
|